Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -17.93x is 98% above its 5-year average of -1014.55x, near the high end of its 5-year range (-4288.70x–-3.97x).
As of the fiscal period ended Tuesday, March 31, 2026. 36.21% above its 12-month average of -28.11x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-03-31): -17.92x.
INTEREST COVERAGE RATIO
-17.93x
INTEREST COVERAGE RATIO AVG TTM
-28.11x
INTEREST COVERAGE RATIO AVG 3Y
-18.99x
INTEREST COVERAGE RATIO AVG 5Y
-1014.55x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+36.21%
CURRENT VS 3Y AVG
+5.58%
CURRENT VS 5Y AVG
+98.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-178.42%
vs the sector median at left
OKYO Pharma Limited
Market Cap
$56.02M
Interest Coverage Ratio
-17.93x
TTM Avg
-28.11x
3Y Avg
-18.99x
5Y Avg
-1014.55x
Market Cap
$57.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$54.14M
Interest Coverage Ratio
-13.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.06M
Interest Coverage Ratio
-31.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.70M
Interest Coverage Ratio
-557.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.02M | -17.93x | -28.11x | -18.99x | -1014.55x |
| Aldeyra The (ALDX)vs › | $55.25M | -18.51x | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | N/A | N/A | N/A |
| Talphera, Inc. (TLPH)vs › | $57.61M | N/A | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -13.25x | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -31.98x | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -557.72x | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | -3392.06x | 18.65x | 15.79x | 19.13x |
Interest Coverage
-17.9x
Debt/Equity
0.00
Current Ratio
2.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -17.92x |
| 2025-09-30 | -33.03x |
| 2025-03-31 | -33.37x |
| 2024-09-30 | -3.97x |
| 2024-03-31 | -6.67x |
| 2021-09-30 | -2718.19x |
| 2021-03-31 | -4288.70x |
